Announcements

Call for Manuscripts: Global South Health Horizons (GSHH)

Dear Esteemed Researchers, Clinicians, and Health Professionals,

Professor Olumide ABIODUN, Editor-in-Chief of Global South Health Horizons (GSHH), invites you to submit your original research, reviews, and perspectives for publication in our upcoming issues.

GSHH is a peer-reviewed, open-access journal dedicated to advancing health equity and evidence-based solutions for the Global South. We publish high-quality research across all health disciplines, with a focus on:

  • Public Health & Epidemiology
  • Clinical Medicine & Surgery
  • Nursing and Allied Health
  • Health Systems & Policy
  • Infectious & Non-Communicable Diseases
  • Maternal, Child, & Adolescent Health
  • Environmental & Occupational Health
  • Digital Health & Innovations
  • Traditional & Complementary Medicine

Why Publish with GSHH?

✔ Rigorous Peer Review: Double-blind review process ensuring quality and fairness.
✔ Rapid Publication: Online-first availability upon acceptance.
✔ Global Visibility: Indexed in Google Scholar and Crossref.
✔ Open AccessCC BY 4.0 license for maximum reach and impact.
✔ Author Support: Waivers available for LMIC researchers (case-by-case basis).
✔ Zero APC: For all submissions till December 31, 2025.

Read the Submission Guidelines

Deadline: Rolling submissions.

Special Issues

We are currently accepting proposals for Special Issues on:

  • Digital Health in LMICs
  • Climate Change and Health Equity
  • Non-Communicable Diseases in the Global South
    Contact gshh@cecr.com.ng for details.

Spread the Word!

Share this call with your networks and colleagues. Together, we can amplify voices from the Global South in global health discourse.

Contact

For inquiries, email: gshh@cecr.com.ng
WhatsApp: +2348061956031

Office Address:
Centre for Epidemiology and Clinical Research
Plot 7 and 8, Block A, Isoso Area,
GRA Quarters, Sagamu,
Ogun State, Nigeria

Join us in shaping the future of health research for the Global South!

Follow us onTwitter | LinkedIn